Director Kiai Parsa Adds $529K More in Medifast Stock, Extending Accumulation Streak
MED sits 30% above its 52-week low of $9.22 on light trading volume (0.1× avg).
Summary
Director Kiai Parsa purchased 43,150 shares of Medifast for $529,157 on August 26, following a larger purchase disclosed days earlier. The buying extends a pattern of insider accumulation amid operational headwinds.
Key Events · Ownership and Investor Activity · MED
-
Director Buys $529K More Stock
Kiai Parsa acquired 43,150 shares at an average price of $12.26 on August 26, 2026, for a total of $529,157.08.
-
Extends Accumulation Streak
This follows a $842,699 purchase disclosed on August 21, bringing Parsa's total open-market buying over the past week to approximately $1.37 million.
-
Steamboat Capital Connection
The shares are held indirectly through Steamboat Capital Partners funds, which recently disclosed a 7.1% stake in Medifast.
-
Operational Headwinds Persist
The purchases come after Q2 2026 revenue fell 27.6% to $76.4M and the company swung to a $3.1M net loss, with active coaches down 48.7% year-over-year.
Analysis · MED · Manufacturing
Director Kiai Parsa bought another $529,157 worth of Medifast stock on August 26, just days after a $842,699 purchase disclosed on August 21. The combined buying over the past week totals roughly $1.37 million, a meaningful show of conviction from a director with ties to Steamboat Capital Partners, which recently disclosed a 7.1% stake. The purchases come against a backdrop of steep revenue declines and a net loss in Q2 2026, making the insider accumulation notable.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MED was trading at $11.95 on NYSE in the Manufacturing sector, with a market capitalization of approximately $133.6M. The 52-week trading range was $9.22 to $14.67. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.